Matches in SemOpenAlex for { <https://semopenalex.org/work/W2982397180> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2982397180 abstract "The boxed warning (also known as black box warning) is one of the FDA's strongest safety actions for pharmaceuticals. After the FDA issues black box warnings for drugs, prescribing changes have been inconsistent. Formulary management may provide an opportunity to restrict access to drugs with serious safety concerns.To examine Medicare prescription drug plan formulary changes after new FDA postmarket black box warnings and major updates to preexisting black box warnings.In this cohort study, we identified each drug that received a new FDA postmarket black box warning or a major update to a preexisting black box warning from January 2008 through June 2015 and examined its formulary coverage. The main outcome measure was the proportion of Medicare prescription drug plan formularies providing unrestrictive coverage immediately before the black box warning, at least 1 year after the warning and at least 2 years after the warning. Unrestrictive formulary coverage was defined as coverage of a drug without prior authorization or step-therapy requirements.Of 101 new black box warnings and major updates to preexisting warnings affecting 68 unique drug formulations, the mean percentage of formularies providing unrestrictive coverage changed from 65.4% (95% CI = 59.6%-71.2%) prewarning; 62.6% (95% CI = 56.3%-68.9%, P = 0.04) at least 1 year postwarning; and 61.9% (95% CI = 55.4%-68.5%, P = 0.10) at least 2 years postwarning.The mean percentage of Medicare prescription drug plan formularies providing unrestrictive coverage decreased modestly by approximately 3 percentage points after drugs received postmarket FDA black box warnings. Formulary restrictions may present an underused mechanism to reduce use of potentially unsafe medications.This study was supported by a student research grant received by Solotke and provided by the Yale School of Medicine Office of Student Research under National Institutes of Health training grant award T35DK104689. Karaca-Mandic, Shah, and Ross acknowledge support from Agency for Healthcare Research and Quality (AHRQ) grant R01 HS025164, which studies factors associated with de-adoption of drug therapies shown to be ineffective or unsafe. The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors assume full responsibility for the accuracy and completeness of the ideas presented. Ross has received support from the following: the U.S. Food and Drug Administration (FDA) as part of the Centers for Excellence in Regulatory Science and Innovation (CERSI) program; Johnson and Johnson through Yale University to develop methods of clinical trial data sharing; Medtronic and the FDA to develop methods for postmarket surveillance of medical devices; the Blue Cross Blue Shield Association to better understand medical technology evaluation; the Centers for Medicare & Medicaid Services (CMS) to develop and maintain performance measures that are used for public reporting; the AHRQ to examine community predictors of health care quality; and the Laura and John Arnold Foundation, which established the Collaboration for Research Integrity and Transparency at Yale University. Shah has received support from the FDA as part of the CERSI program. In addition, he has received support through the Mayo Clinic from CMS, AHRQ, National Science Foundation, and Patient-centered Outcomes Research Institute. Karaca-Mandic has provided consulting services to Precision Health Economics and Tactile Medical for work unrelated to this manuscript. Dhruva and Solotke have no conflicts of interest to report." @default.
- W2982397180 created "2019-11-08" @default.
- W2982397180 creator A5004332544 @default.
- W2982397180 creator A5031832642 @default.
- W2982397180 creator A5041424888 @default.
- W2982397180 creator A5066131505 @default.
- W2982397180 creator A5068750234 @default.
- W2982397180 date "2019-11-01" @default.
- W2982397180 modified "2023-09-25" @default.
- W2982397180 title "Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings" @default.
- W2982397180 cites W1977710728 @default.
- W2982397180 cites W1981599458 @default.
- W2982397180 cites W2003370576 @default.
- W2982397180 cites W2019007750 @default.
- W2982397180 cites W2022298818 @default.
- W2982397180 cites W2035786417 @default.
- W2982397180 cites W2080033724 @default.
- W2982397180 cites W2105082851 @default.
- W2982397180 cites W2107823647 @default.
- W2982397180 cites W2117979215 @default.
- W2982397180 cites W2129906534 @default.
- W2982397180 cites W2146125338 @default.
- W2982397180 cites W2148105959 @default.
- W2982397180 cites W2163471236 @default.
- W2982397180 cites W2166309454 @default.
- W2982397180 cites W2297401656 @default.
- W2982397180 cites W2319689835 @default.
- W2982397180 cites W2325195519 @default.
- W2982397180 cites W2411133793 @default.
- W2982397180 cites W2586805675 @default.
- W2982397180 cites W2602824263 @default.
- W2982397180 cites W2612600212 @default.
- W2982397180 cites W2740016262 @default.
- W2982397180 cites W2750636690 @default.
- W2982397180 cites W2759476089 @default.
- W2982397180 cites W2772686065 @default.
- W2982397180 doi "https://doi.org/10.18553/jmcp.2019.25.11.1201" @default.
- W2982397180 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31663461" @default.
- W2982397180 hasPublicationYear "2019" @default.
- W2982397180 type Work @default.
- W2982397180 sameAs 2982397180 @default.
- W2982397180 citedByCount "1" @default.
- W2982397180 countsByYear W29823971802020 @default.
- W2982397180 crossrefType "journal-article" @default.
- W2982397180 hasAuthorship W2982397180A5004332544 @default.
- W2982397180 hasAuthorship W2982397180A5031832642 @default.
- W2982397180 hasAuthorship W2982397180A5041424888 @default.
- W2982397180 hasAuthorship W2982397180A5066131505 @default.
- W2982397180 hasAuthorship W2982397180A5068750234 @default.
- W2982397180 hasBestOaLocation W29823971801 @default.
- W2982397180 hasConcept C100406419 @default.
- W2982397180 hasConcept C104863432 @default.
- W2982397180 hasConcept C160735492 @default.
- W2982397180 hasConcept C162324750 @default.
- W2982397180 hasConcept C2426938 @default.
- W2982397180 hasConcept C2776291444 @default.
- W2982397180 hasConcept C2778829437 @default.
- W2982397180 hasConcept C2778858636 @default.
- W2982397180 hasConcept C2779598192 @default.
- W2982397180 hasConcept C2780035454 @default.
- W2982397180 hasConcept C50522688 @default.
- W2982397180 hasConcept C512399662 @default.
- W2982397180 hasConcept C71924100 @default.
- W2982397180 hasConcept C98274493 @default.
- W2982397180 hasConceptScore W2982397180C100406419 @default.
- W2982397180 hasConceptScore W2982397180C104863432 @default.
- W2982397180 hasConceptScore W2982397180C160735492 @default.
- W2982397180 hasConceptScore W2982397180C162324750 @default.
- W2982397180 hasConceptScore W2982397180C2426938 @default.
- W2982397180 hasConceptScore W2982397180C2776291444 @default.
- W2982397180 hasConceptScore W2982397180C2778829437 @default.
- W2982397180 hasConceptScore W2982397180C2778858636 @default.
- W2982397180 hasConceptScore W2982397180C2779598192 @default.
- W2982397180 hasConceptScore W2982397180C2780035454 @default.
- W2982397180 hasConceptScore W2982397180C50522688 @default.
- W2982397180 hasConceptScore W2982397180C512399662 @default.
- W2982397180 hasConceptScore W2982397180C71924100 @default.
- W2982397180 hasConceptScore W2982397180C98274493 @default.
- W2982397180 hasLocation W29823971801 @default.
- W2982397180 hasLocation W29823971802 @default.
- W2982397180 hasOpenAccess W2982397180 @default.
- W2982397180 hasPrimaryLocation W29823971801 @default.
- W2982397180 hasRelatedWork W1976294525 @default.
- W2982397180 hasRelatedWork W2102273617 @default.
- W2982397180 hasRelatedWork W2407308897 @default.
- W2982397180 hasRelatedWork W2624306162 @default.
- W2982397180 hasRelatedWork W2920822829 @default.
- W2982397180 hasRelatedWork W2941242455 @default.
- W2982397180 hasRelatedWork W2972883156 @default.
- W2982397180 hasRelatedWork W2982397180 @default.
- W2982397180 hasRelatedWork W48122609 @default.
- W2982397180 hasRelatedWork W2195038299 @default.
- W2982397180 isParatext "false" @default.
- W2982397180 isRetracted "false" @default.
- W2982397180 magId "2982397180" @default.
- W2982397180 workType "article" @default.